A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancer

Completed · Phase 1

Conditions studied: Esophageal Cancer

In brief

The purpose of this study is to evaluate the investigators ability to obtain reliable and meaningful 11C-Choline PET-CT images of esophageal cancer.

Key facts

Study ID

NCT01051479

Run by

Wake Forest University Health Sciences

People needed

22

Starts

2010-03-01

Expected to finish

2013-08-01

Last updated by the study team

2018-07-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Newly diagnosed or recurrent patients with locally advanced esophageal cancer with either squamous or adenocarcinoma histology.
• Ability to tolerate PET imaging
• Prior malignancy is allowed, but the expectation of survival must be that beyond that expected for patients with locally advanced esophageal cancer.

You may not qualify if…

• Pregnant or lactating females are not eligible for this pilot study.
• Patients having received chemotherapy in the 3 months prior to registration for any reason
• Patients with metastatic disease requiring chemoradiation for palliation are not allowed.

Where it is running

• Wake Forest University Health Sciences — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.